Abraham Chesed insider trades: Turn Therapeutics (TTRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Abraham reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | TTRX | ↑ Buy | 14,286 | $4.60 | $66K | By ANC Merchant FLP and ANC Carlson FLP | Oct 29, 2025 (6d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TTRX insiders
Open-market trades in the last 12 months
About Abraham Chesed's insider trades
Abraham Chesed is an insider at Turn Therapeutics (TTRX). Since Oct 23, 2025, Abraham has reported 1 open-market purchase worth $66K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TTRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.